ArticleRheumatology (Oxford, England)2020

Disease activity measures at baseline predict structural damage progression: data from the randomized, controlled AMPLE and AVERT trials.

Edward C Keystone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.